Answers are grounded in this paper and cite their sources.
This large multicentre cohort study has found several genetic and clinical factors influencing the clinical course of CD. NOD2 and early immunomodulator use are the clinically most meaningful predictors for its clinical course.
No takes yet. Share an insight, caveat, or question.
Cleynen et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: